Isolation and characterization of atropisomers of seven-membered-ring benzolactams

Journal of Organic Chemistry

Volumn 76, Issue 12, 2011, Pages 5123-5131

  Tabata, Hidetsugu ^a   Wada, Naoya ^a   Takada, Yuko ^a   Oshitari, Tetsuta ^a   Takahashi, Hideyo ^a   Natsugari, Hideaki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; ORGANIC COMPOUNDS;

ATROPISOMERS; DIASTEREOMERS; INTERCONVERSIONS; ISOLATION AND CHARACTERIZATION; SEVEN-MEMBERED RINGS;

X RAY CRYSTALLOGRAPHY;

1 BENZAZEPIN 2 ONE; 1,5 BENZODIAZEPIN 2 ONE; 1,5 BENZOTHIAZEPIN 4 ONE; BENZOLACTAM; LACTAM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DIASTEREOISOMER; ISOMER; ISOMERISM; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

EID: 79958834708     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo2008725     Document Type: Article

References (36)

1. Khan, K. M.; Malik, F.; Snatzke, G.; Voelter, W. Z. Naturforsch. 1996, 51b, 588-598
2. Bariwal, J. B.; Upadhyay, K. D.; Manvar, A. T.; Trivedi, J. C.; Singh, J. S.; Jain, K. S.; Shah, A. K. Eur. J. Med. Chem. 2008, 43, 2279-2290
3. Watthey, J. W. H.; Stanton, J. L.; Desai, M.; Babiarz, J. E.; Finn, B. M. J. Med. Chem. 1985, 28, 1511-1516
4. For studies on conformation including the atropisomeric property of the 3 H -1,4-benzodiazepine nucleus, see: Gilman, N. W.; Rosen, P.; Earley, J. V.; Cook, C.; Todaro, L. J. J. Am. Chem. Soc. 1990, 112, 3969-3978
5. Carlier, P. R.; Zhao, H.; DeGuzman, J.; Lam, P. C.-H. J. Am. Chem. Soc. 2003, 125, 11482-11483
6. Carlier, P. R.; Zhao, H.; MacQuarrie-Hunter, S. L.; DeGuzman, J. C.; Hsu, D. C. J. Am. Chem. Soc. 2006, 128, 15215-15220
7. Lee, S.; Kamide, T.; Tabata, H.; Takahashi, H.; Shiro, M.; Natsugari, H. Bioorg. Med. Chem. 2008, 16, 9519-9523
8. Carlier, P. R.; Sun, Y.-S.; Hsu, D. C.; Chen, Q.-H. J. Org. Chem. 2010, 75, 6588-6594
9. 2 axis at Ar-N(C=O) may play a key role.
10. For review articles on axial chirality and atropisomerism, see: Clayden, J. Tetrahedron 2004, 60, 4335 in Tetrahedron Symposia-in-Print on Atropisomerism (Clayden, J., Ed.) and other papers in the issue.
11. Clayden, J.; Moran, W. J.; Edwards, P. J.; LaPlante, S. R. Angew. Chem., Int. Ed. 2009, 48, 6398-6401
12. Tabata, H.; Akiba, K.; Shoukou, L.; Takahashi, H.; Natsugari, H. Org. Lett. 2008, 10, 4871-4874
13. Tabata, H.; Suzuki, H.; Akiba, K.; Takahashi, H.; Natsugari, H. J. Org. Chem. 2010, 75, 5984-5993
14. Lanz, T. A.; Hosly, J. D.; Adams, W. J.; Merchant, K. M. J. Pharmacol. Exp. Ther. 2004, 309, 49-55
15. Fuwa, H.; Okamura, Y.; Morohashi, Y.; Tomita, T.; Iwatsubo, T.; Kan, T.; Fukuyama, T.; Natsugari, H. Tetrahedron Lett. 2004, 45, 2323-2326
16. Cole, K. P.; Mitchell, D.; Carr, M. A.; Stout, J. R.; Belvo, M. D. Tetrahedron: Asymmetry 2009, 20, 1262-1266
17. 2 axis of the aryl-amide bond in biologically active compounds, see: Eveleigh, P.; Hulme, E. C.; Schudt, C.; Birdsall, N. J. M. Mol. Pharmacol. 1989, 35, 477-483
18. Natsugari, H.; Ikeura, Y.; Kamo, I.; Ishimaru, T.; Ishichi, Y.; Fujishima, A.; Tanaka, T.; Kasahara, F.; Kawada, M.; Doi, T. J. Med. Chem. 1999, 42, 3982-3993
19. Albert, J. S.; Aharony, D.; Andisik, D.; Barthlow, H.; Bernstein, P. R.; Bialecki, R. A.; Dedinas, R.; Dembofsky, B. T.; Hill, D.; Kirkland, K.; Koether, G. M.; Kosmider, B. J.; Ohnmacht, C.; Palmer, W.; Potts, W.; Rumsey, W.; Shen, L.; Shenvi, A.; Sherwood, S.; Warwick, P. J.; Russell, K. J. Med. Chem. 2002, 45, 3972-3983
20. Guile, S. D.; Bantick, J. R.; Cooper, M. E.; Donald, D. K.; Eyssade, C.; Ingall, A. H.; Lewis, R. J.; Martin, B. P.; Mohammed, R. T.; Potter, T. J.; Reynolds, R. H.; St-Gallay, S. A.; Wright, A. D. J. Med. Chem. 2007, 50, 254-263
21. Welch, C. J.; Biba, M.; Pye, P.; Angelaud, R.; Egbertson, M. J. Chromatogr. B 2008, 875, 118-121
22. Porter, J.; Payne, A.; Whitcombe, I.; de Candole, B.; Ford, D.; Garlish, R.; Hold, A.; Hutchinson, B.; Trevitt, G.; Turner, J.; Edwards, C.; Watkins, C.; Davis, J.; Stubberfield, C. Bioorg. Med. Chem. Lett. 2009, 19, 1767-1772
23. Takahashi, H; Wakamatsu, S.; Tabata, H; Oshitari, T.; Harada, A.; Inoue, K.; Natsugari, H. Org. Lett. 2011, 13, 760-763
24. Tabata, H; Nakagomi, J.; Morizono, D.; Oshitari, T.; Takahashi, H.; Natsugari, H. Angew. Chem., Int. Ed. 2011, 50, 3075-3079
25. Hussenether, T.; Hübner, H.; Gmeiner, P.; Troschütz, R. Bioorg. Med. Chem. 2004, 12, 2625-2637
26. Ambrogi, V.; Grandolini, G. Syntesis 1987, 724-726
27. Luca, L. D.; Giacomelli, G.; Porcheddu, A. J. Org. Chem. 2002, 67, 6272-6274
28. Nieduzak, T. D.; Boyer, F. E. Synth. Commun. 1996, 26, 3443-3452
29. ⧧) value estimated from this analysis was ca. 56 kJ/mol. See the Supporting Information.
30. Note that the definition of the axial chirality (a S and a R) leads to reversed stereochemical designations between 5, 7 (Y = Cl) and 6, 8 (Y = Ph) according to the priority rule. The terms a S and a R (chiral axis nomenclature) correspond to P and M (helix nomenclature), respectively.
31. The absolute stereochemistry was determined based on the Flack parameter (Cu Kα radiation was used for the measurement).
32. 4 of 7a / 7c according to the numbering rule.
33. ⧧ value, see: Petit, M.; Lapierre, A. J. B.; Curran, D. P. J. Am. Chem. Soc. 2005, 127, 14994-14995
34. White, W. N.; Klink, J. R. J. Org. Chem. 1977, 42, 166-169
35. Gupta, R. R.; Ojha, K. G.; Kumar, M. J. Heterocycl. Chem. 1980, 17, 1325-1327
36. Nguyen, P.; Corpuz, E.; Heidelbaugh, T. M.; Chow, K.; Garst, M. E. J. Org. Chem. 2003, 68, 10195-10198